Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-20-000195

GENERAL COUNSEL/CORPORATE SECR gave up 2,166 shares (to pay taxes)

  • GENERAL COUNSEL/CORPORATE SECR acquired 6,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Belloff Neil S. GENERAL COUNSEL/CORPORATE SECR 2020-01-30 Option exercise +6,250 6,250 D
Belloff Neil S. GENERAL COUNSEL/CORPORATE SECR 2020-01-30 Shares withheld for taxes −2,166 $3.91 $8,469 4,084 D
Derivatives
Belloff Neil S. GENERAL COUNSEL/CORPORATE SECR 2020-01-30 Option exercise · Restricted Stock Units +6,250 18,750 D
Loading xslF345X03/form4-01312020_050102.xml…